Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TP53 mutation
i
Other names:
TP53, Tumor Protein P53, Cellular Tumor Antigen P53, Phosphoprotein P53, Tumor Protein P53, Antigen NY-CO-13, Transformation-Related Protein 53, Mutant Tumor Protein 53, P53 Tumor Suppressor, Tumor Suppressor P53, Tumor Protein 53, BMFS5, TRP53, BCC7, LFS1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
7157
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
TP53 wild-type (46)
EGFR mutation + TP53 mutation (11)
TP53 R175H (8)
BRCA1 2110_2111delAA + BRCA1 4071_4096 +14del40 + TP53 R342P + NOTCH2 Q1310H (7)
TP53 mutation + KRAS mutation (6)
ALK rearrangement + TP53 mutation (4)
KRAS G12C + TP53 mutation (3)
BRCA1 mutation + TP53 mutation (2)
BRCA2 mutation + TP53 mutation (2)
CDKN2A mutation + TP53 mutation (2)
EGFR L858R + TP53 mutation (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
EGFR mutation + TP53 mutation + BRCA1 mutation (2)
EGFR mutation + TP53 mutation + NF1 mutation (2)
EGFR mutation + TP53 mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + RB1 mutation (2)
KRAS mutation + TP53 wild-type (2)
STK11 mutation + TP53 mutation (2)
TP53 P190T (2)
TP53 R248Q (2)
TP53 T175H + PIK3CA H1047R (2)
TP53 Y220C (2)
TP53 mutation + PIK3CA mutation + CD74 mutation (2)
AHNAK2 mutation + TP53 mutation (1)
ALK rearrangement + ALK L1196M + TP53 mutation (1)
ALK rearrangement + ALK R1275Q + TP53 mutation (1)
ALK rearrangement + TP53 R175H + EGFR A839V + PI3KCA mutation (1)
ALK rearrangement + TP53 wild-type (1)
ATRX mutation + TP53 mutation + PTEN mutation (1)
BRAF G466E + NF1 Y2285fs*5 + NF1 Y2640fs*3 + TP53 D281Y (1)
BRAF N486-P490del + TP53 V157G (1)
BRAF mutation + TP53 mutation (1)
BRCA1 mutation + TP53 R248Q (1)
BRCA2 Y1655* + TP53 mutation (1)
BRCA2 mutation + TP53 D816Y (1)
CXCR4 S338X + TP53 R196X (1)
DSPP mutation + TP53 mutation (1)
EGFR G719X + TP53 mutation (1)
EGFR L718V + TP53 V727M + EGFR L858R (1)
EGFR L858R + TP53 R273C + HER-2 S442L (1)
EGFR L858R + TP53 wild-type (1)
EGFR L861Q + TP53 mutation (1)
EGFR L861Q + TP53 mutation + RB1 mutation (1)
EGFR S768I + TP53 mutation (1)
EGFR T790M + TP53 R237C (1)
EGFR exon 19 deletion + TP53 exon 8 mutation (1)
EGFR exon 19 deletion + TP53 mutation (1)
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation (1)
EGFR mutation + BRAF mutation + TP53 mutation (1)
EGFR mutation + TP53 exon 6 mutation (1)
EGFR mutation + TP53 exon 7 mutation (1)
EGFR T790M + TP53 mutation (1)
HER-2 mutation + TP53 wild-type (1)
IDH1 mutation + TP53 mutation (1)
IDH2 mutation + TP53 mutation (1)
KMT2C mutation + TP53 mutation (1)
KRAS G12V + TP53 mutation + APC mutation (1)
KRAS mutation + STK11 mutation + TP53 mutation (1)
MET exon 14 mutation + TP53 mutation (1)
NF1 L581Ffs*6 + KRAS A146P + NRAS Q61K + TP53 R175H + PD-L1 T290M (1)
PTEN mutation + TP53 mutation (1)
RB1 mutation + TP53 mutation (1)
TERT mutation + TP53 mutation (1)
TP53 -181_-179delAAA (1)
TP53 273H (1)
TP53 A159V (1)
TP53 D281E (1)
TP53 G245S + ALK rearrangement (1)
TP53 N263D (1)
TP53 Q38fs (1)
TP53 R172H (1)
TP53 R209fs* (1)
TP53 R273H (1)
TP53 R333Vfs*12 (1)
TP53 W146* (1)
TP53 exon 4 mutation (1)
TP53 exon 5 mutation (1)
TP53 exon 8 mutation (1)
TP53 mutation + ARID1A mutation (1)
TP53 mutation + ATM mutation (1)
TP53 mutation + BCL2 rearrangement (1)
TP53 mutation + CARD11 mutation + SMARCA4 mutation (1)
TP53 mutation + FGFR2 rearrangement (1)
TP53 mutation + IKZF1 mutation (1)
TP53 mutation + IKZF3 mutation (1)
TP53 mutation + MDM2 mutation (1)
TP53 mutation + NOTCH4 mutation (1)
TP53 mutation + NTRK3 mutation (1)
TP53 mutation + TSC2 mutation (1)
TP53 mutation + TTN mutation (1)
TP53 mutation + ZFHX3 mutation (1)
TP53 wild-type + LRP1B wild-type (1)
TP53 G245S (1)
ALK mutation + TP53 mutation (0)
KRAS mutation + TP53 mutation (0)
NOTCH S2435S + TP53 G245A + TP53 P190T + TP53 FBXW7 + TP53 G477S (0)
TP53 H179Y (0)
TP53 I255N (0)
TP53 K139N (0)
TP53 Q16fs*28 (0)
TP53 R196* (0)
TP53 R213 (0)
TP53 R273C (0)
TP53 T175H (0)
TP53 V157G (0)
TP53 exon 6 mutation (0)
TP53 exon 7 mutation (0)
TP53 wild-type (46)
EGFR mutation + TP53 mutation (11)
TP53 R175H (8)
BRCA1 2110_2111delAA + BRCA1 4071_4096 +14del40 + TP53 R342P + NOTCH2 Q1310H (7)
TP53 mutation + KRAS mutation (6)
ALK rearrangement + TP53 mutation (4)
KRAS G12C + TP53 mutation (3)
BRCA1 mutation + TP53 mutation (2)
BRCA2 mutation + TP53 mutation (2)
CDKN2A mutation + TP53 mutation (2)
EGFR L858R + TP53 mutation (2)
EGFR mutation + TP53 mutation + ARID1A mutation (2)
EGFR mutation + TP53 mutation + BRCA1 mutation (2)
EGFR mutation + TP53 mutation + NF1 mutation (2)
EGFR mutation + TP53 mutation + PTEN mutation (2)
EGFR mutation + TP53 mutation + RB1 mutation (2)
KRAS mutation + TP53 wild-type (2)
STK11 mutation + TP53 mutation (2)
TP53 P190T (2)
TP53 R248Q (2)
TP53 T175H + PIK3CA H1047R (2)
TP53 Y220C (2)
TP53 mutation + PIK3CA mutation + CD74 mutation (2)
AHNAK2 mutation + TP53 mutation (1)
ALK rearrangement + ALK L1196M + TP53 mutation (1)
ALK rearrangement + ALK R1275Q + TP53 mutation (1)
ALK rearrangement + TP53 R175H + EGFR A839V + PI3KCA mutation (1)
ALK rearrangement + TP53 wild-type (1)
ATRX mutation + TP53 mutation + PTEN mutation (1)
BRAF G466E + NF1 Y2285fs*5 + NF1 Y2640fs*3 + TP53 D281Y (1)
BRAF N486-P490del + TP53 V157G (1)
BRAF mutation + TP53 mutation (1)
BRCA1 mutation + TP53 R248Q (1)
BRCA2 Y1655* + TP53 mutation (1)
BRCA2 mutation + TP53 D816Y (1)
CXCR4 S338X + TP53 R196X (1)
DSPP mutation + TP53 mutation (1)
EGFR G719X + TP53 mutation (1)
EGFR L718V + TP53 V727M + EGFR L858R (1)
EGFR L858R + TP53 R273C + HER-2 S442L (1)
EGFR L858R + TP53 wild-type (1)
EGFR L861Q + TP53 mutation (1)
EGFR L861Q + TP53 mutation + RB1 mutation (1)
EGFR S768I + TP53 mutation (1)
EGFR T790M + TP53 R237C (1)
EGFR exon 19 deletion + TP53 exon 8 mutation (1)
EGFR exon 19 deletion + TP53 mutation (1)
EGFR exon 20 insertion + TP53 G244A + SPTA1 mutation (1)
EGFR mutation + BRAF mutation + TP53 mutation (1)
EGFR mutation + TP53 exon 6 mutation (1)
EGFR mutation + TP53 exon 7 mutation (1)
EGFR T790M + TP53 mutation (1)
HER-2 mutation + TP53 wild-type (1)
IDH1 mutation + TP53 mutation (1)
IDH2 mutation + TP53 mutation (1)
KMT2C mutation + TP53 mutation (1)
KRAS G12V + TP53 mutation + APC mutation (1)
KRAS mutation + STK11 mutation + TP53 mutation (1)
MET exon 14 mutation + TP53 mutation (1)
NF1 L581Ffs*6 + KRAS A146P + NRAS Q61K + TP53 R175H + PD-L1 T290M (1)
PTEN mutation + TP53 mutation (1)
RB1 mutation + TP53 mutation (1)
TERT mutation + TP53 mutation (1)
TP53 -181_-179delAAA (1)
TP53 273H (1)
TP53 A159V (1)
TP53 D281E (1)
TP53 G245S + ALK rearrangement (1)
TP53 N263D (1)
TP53 Q38fs (1)
TP53 R172H (1)
TP53 R209fs* (1)
TP53 R273H (1)
TP53 R333Vfs*12 (1)
TP53 W146* (1)
TP53 exon 4 mutation (1)
TP53 exon 5 mutation (1)
TP53 exon 8 mutation (1)
TP53 mutation + ARID1A mutation (1)
TP53 mutation + ATM mutation (1)
TP53 mutation + BCL2 rearrangement (1)
TP53 mutation + CARD11 mutation + SMARCA4 mutation (1)
TP53 mutation + FGFR2 rearrangement (1)
TP53 mutation + IKZF1 mutation (1)
TP53 mutation + IKZF3 mutation (1)
TP53 mutation + MDM2 mutation (1)
TP53 mutation + NOTCH4 mutation (1)
TP53 mutation + NTRK3 mutation (1)
TP53 mutation + TSC2 mutation (1)
TP53 mutation + TTN mutation (1)
TP53 mutation + ZFHX3 mutation (1)
TP53 wild-type + LRP1B wild-type (1)
TP53 G245S (1)
ALK mutation + TP53 mutation (0)
KRAS mutation + TP53 mutation (0)
NOTCH S2435S + TP53 G245A + TP53 P190T + TP53 FBXW7 + TP53 G477S (0)
TP53 H179Y (0)
TP53 I255N (0)
TP53 K139N (0)
TP53 Q16fs*28 (0)
TP53 R196* (0)
TP53 R213 (0)
TP53 R273C (0)
TP53 T175H (0)
TP53 V157G (0)
TP53 exon 6 mutation (0)
TP53 exon 7 mutation (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + obinutuzumab
Sensitive: A1 - Approval
venetoclax + obinutuzumab
Sensitive
:
A1
venetoclax + obinutuzumab
Sensitive: A1 - Approval
venetoclax + obinutuzumab
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax
Sensitive: A1 - Approval
venetoclax
Sensitive
:
A1
venetoclax
Sensitive: A1 - Approval
venetoclax
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + idelalisib
Sensitive: A1 - Approval
rituximab + idelalisib
Sensitive
:
A1
rituximab + idelalisib
Sensitive: A1 - Approval
rituximab + idelalisib
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
acalabrutinib
Sensitive: A1 - Approval
acalabrutinib
Sensitive
:
A1
acalabrutinib
Sensitive: A1 - Approval
acalabrutinib
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
idelalisib + ofatumumab
Sensitive: A1 - Approval
idelalisib + ofatumumab
Sensitive
:
A1
idelalisib + ofatumumab
Sensitive: A1 - Approval
idelalisib + ofatumumab
Sensitive
:
A1
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
pirtobrutinib
Sensitive: A2 - Guideline
pirtobrutinib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
zanubrutinib
Sensitive: A2 - Guideline
zanubrutinib
Sensitive
:
A2
zanubrutinib
Sensitive: A2 - Guideline
zanubrutinib
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
zanubrutinib
Sensitive: A2 - Guideline
zanubrutinib
Sensitive
:
A2
zanubrutinib
Sensitive: A2 - Guideline
zanubrutinib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
rituximab
Sensitive: A2 - Guideline
rituximab
Sensitive
:
A2
rituximab
Sensitive: A2 - Guideline
rituximab
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
ibrutinib
Sensitive: A2 - Guideline
ibrutinib
Sensitive
:
A2
ibrutinib
Sensitive: A2 - Guideline
ibrutinib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
ibrutinib
Sensitive: A2 - Guideline
ibrutinib
Sensitive
:
A2
ibrutinib
Sensitive: A2 - Guideline
ibrutinib
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
venetoclax + ibrutinib
Sensitive: A2 - Guideline
venetoclax + ibrutinib
Sensitive
:
A2
venetoclax + ibrutinib
Sensitive: A2 - Guideline
venetoclax + ibrutinib
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
idelalisib
Sensitive: A2 - Guideline
idelalisib
Sensitive
:
A2
idelalisib
Sensitive: A2 - Guideline
idelalisib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
idelalisib
Sensitive: A2 - Guideline
idelalisib
Sensitive
:
A2
idelalisib
Sensitive: A2 - Guideline
idelalisib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
venetoclax
Sensitive: A2 - Guideline
venetoclax
Sensitive
:
A2
venetoclax
Sensitive: A2 - Guideline
venetoclax
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
rituximab + idelalisib
Sensitive: A2 - Guideline
rituximab + idelalisib
Sensitive
:
A2
rituximab + idelalisib
Sensitive: A2 - Guideline
rituximab + idelalisib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
duvelisib
Sensitive: A2 - Guideline
duvelisib
Sensitive
:
A2
duvelisib
Sensitive: A2 - Guideline
duvelisib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
venetoclax + rituximab
Sensitive: A2 - Guideline
venetoclax + rituximab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
obinutuzumab
Sensitive: A2 - Guideline
obinutuzumab
Sensitive
:
A2
obinutuzumab
Sensitive: A2 - Guideline
obinutuzumab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
alemtuzumab
Sensitive: A2 - Guideline
alemtuzumab
Sensitive
:
A2
alemtuzumab
Sensitive: A2 - Guideline
alemtuzumab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
rituximab + alemtuzumab
Sensitive: A2 - Guideline
rituximab + alemtuzumab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
venetoclax + obinutuzumab
Sensitive: A2 - Guideline
venetoclax + obinutuzumab
Sensitive
:
A2
venetoclax + obinutuzumab
Sensitive: A2 - Guideline
venetoclax + obinutuzumab
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
acalabrutinib
Sensitive: A2 - Guideline
acalabrutinib
Sensitive
:
A2
acalabrutinib
Sensitive: A2 - Guideline
acalabrutinib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
obinutuzumab + acalabrutinib
Sensitive: A2 - Guideline
obinutuzumab + acalabrutinib
Sensitive
:
A2
obinutuzumab + acalabrutinib
Sensitive: A2 - Guideline
obinutuzumab + acalabrutinib
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
lenalidomide
Sensitive: A2 - Guideline
lenalidomide
Sensitive
:
A2
lenalidomide
Sensitive: A2 - Guideline
lenalidomide
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
lenalidomide
Sensitive: A2 - Guideline
lenalidomide
Sensitive
:
A2
lenalidomide
Sensitive: A2 - Guideline
lenalidomide
Sensitive
:
A2
TP53 mutation
Small Lymphocytic Lymphoma
TP53 mutation
Small Lymphocytic Lymphoma
rituximab + lenalidomide
Sensitive: A2 - Guideline
rituximab + lenalidomide
Sensitive
:
A2
rituximab + lenalidomide
Sensitive: A2 - Guideline
rituximab + lenalidomide
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab + lenalidomide
Sensitive: A2 - Guideline
rituximab + lenalidomide
Sensitive
:
A2
rituximab + lenalidomide
Sensitive: A2 - Guideline
rituximab + lenalidomide
Sensitive
:
A2
TP53 mutation
Chronic Lymphocytic Leukemia
TP53 mutation
Chronic Lymphocytic Leukemia
rituximab
Sensitive: A2 - Guideline
rituximab
Sensitive
:
A2
rituximab
Sensitive: A2 - Guideline
rituximab
Sensitive
:
A2
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login